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Contemporary Outcomes After the Fontan Procedure
A Pediatric Heart Network Multicenter Study
Page A. W. Anderson, MD,* Lynn A. Sleeper, SCD,† Lynn Mahony, MD,‡ Steven D. Colan, MD,§
Andrew M. Atz, MD, Roger E. Breitbart, MD,§ Welton M. Gersony, MD,¶ Dianne Gallagher, MS,†
Tal Geva, MD,§ Renee Margossian, MD,§ Brian W. McCrindle, MD, MPH,# Stephen Paridon, MD,**
Marcy Schwartz, MD,§ Mario Stylianou, PHD,†† Richard V. Williams, MD,‡‡ Bernard J. Clark III, MD,**
for the Pediatric Heart Network Investigators
Durham, North Carolina; Watertown and Boston, Massachusetts; Dallas, Texas; Charleston, South Carolina;
New York, New York; Toronto, Ontario, Canada; Philadelphia, Pennsylvania; Bethesda, Maryland;
and Salt Lake City, Utah
Objectives We characterized a large cohort of children who had a Fontan procedure, with measures of functional health
status, ventricular size and function, exercise capacity, heart rhythm, and brain natriuretic peptide (BNP).
Background The characteristics of contemporary Fontan survivors are not well described.
Methods We enrolled 546 children (age 6 to 18 years, mean 11.9 years) and compared them within pre-specified ana-
tomic and procedure subgroups. History and outcome measures were obtained within a 3-month period.
Results Predominant ventricular morphology was 49% left ventricular (LV), 34% right ventricular (RV), and 19% mixed.
Ejection fraction (EF) was normal for 73% of subjects; diastolic function grade was normal for 28%. Child Health
Questionnaire mean summary scores were lower than for control subjects; however, over 80% of subjects were
in the normal range. Brain natriuretic peptide concentration ranged from 4 to 652 pg/ml (median 13 pg/ml).
Mean percent predicted peak O2 consumption was 65% and decreased with age. Ejection fraction and EF Z
score were lowest, and semilunar and atrioventricular (AV) valve regurgitation were more prevalent in the RV
subgroup. Older age at Fontan was associated with more severe AV valve regurgitation. Most outcomes were not
associated with a superior cavopulmonary connection before Fontan.
Conclusions Measures of ventricular systolic function and functional health status, although lower on average in the cohort
compared with control subjects, were in the majority of subjects within 2 standard deviations of the mean for
control subjects. Right ventricular morphology was associated with poorer ventricular and valvular function. Ef-
fective strategies to preserve ventricular and valvular function, particularly for patients with RV morphology, are
needed. (J Am Coll Cardiol 2008;52:85–98) © 2008 by the American College of Cardiology Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2008.01.074e
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children who have undergone a Fontan procedure for
alliation of a functional single ventricle are at risk for
edical complications (1). Current therapy is based on
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008, accepted January 26, 2008.xpert opinion, retrospective data collection, and single
enter small studies. Robust clinical trials are needed to
uide care for this population. Trial design requires careful
henotyping and understanding of factors that affect out-
omes. To this end, the National Heart, Lung, and Blood
nstitute–funded Pediatric Heart Network (PHN) con-
ucted the largest observational study to date in children
See page 114
ho have undergone a Fontan procedure. The primary aim
f this report is to characterize this cohort and specific
ubgroups, with state-of-the-science techniques to assess
unctional health status, ventricular size and function, exer-
ise performance, brain natriuretic peptide (BNP) concen-
ration, and heart rhythm.
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Study design and components.
This cross-sectional study re-
cruited subjects age 6 to 18 years
old who had not undergone car-
diac surgical intervention in the 6
months before enrollment (2).
Anatomic, clinical, and surgical
data were collected at enrollment
(March 2003 to April 2004) by a
detailed medical record review
with standardized forms. Each
subject’s tests were conducted
within 3 months. The protocol
was approved by each center’s
institutional review board. Writ-
ten informed consent and assent
were obtained.
Patient sample. A total of
1,078 subjects from 7 centers in
the U.S. and Canada were
screened; 644 were study eligible,
and 546 were enrolled (86% con-
sent rate) (2). Age, time since the
Fontan procedure, and func-
tional health status scores, col-
lected for nearly all eligible sub-
jects, were similar for enrolled
nd eligible but not enrolled subjects.
utcome measures. MEASURES OF FUNCTIONAL HEALTH
TATUS. The Physical and Psychosocial Summary scores of
he Child Health Questionnaire (CHQ)-Parent Form (PF)
0 were used (3). The CHQ-PF50 has been validated in
ealthy and chronically ill children and used as a trial end
oint in pediatrics (4).
EASURES OF VENTRICULAR FUNCTION AND SIZE. Echocar-
iogram. The 2-dimensional echocardiograms and Doppler
valuations of standard short- and long-axis views of the
entricle(s) were centrally interpreted by 1 of 2 readers.
hen possible, measurements and derived indexes were
xpressed as Z scores relative to body surface area (BSA) or
ge in normal children (5). Ventricular anatomic abnormal-
ties (Table 1) were characterized as left ventricular (LV),
ight ventricular (RV), or mixed (e.g., unbalanced atrioven-
ricular [AV] canal). Subjects were classified as having
oderate/severe valve regurgitation if RV, LV, or common
V valve regurgitation was moderate or severe; both right
nd left AV valve regurgitation grades were mild; native
ortic valve or native pulmonary valve regurgitation was
oderate or severe; or both native aortic valve and native
ulmonary valve regurgitation grades were mild. End-
iastolic volume (EDV), end-systolic volume (ESV), and
ass were obtained with the biplane-modified Simpson’s
ethod. For the mixed morphology group, the volume and
Abbreviations
and Acronyms
AV  atrioventricular
BNP  brain natriuretic
peptide
BSA  body surface area
CMR  cardiac magnetic
resonance
E  atrioventricular valve
peak early diastolic inflow
velocity
E=  tissue Doppler peak
early diastolic velocity
EDV  end-diastolic volume
EF  ejection fraction
ESV  end-systolic volume
FP  systemic ventricular
flow propagation rate
LV  left
ventricle/ventricular
RV  right
ventricle/ventricular
SV  stroke volume
VAT  peak oxygen
consumption at anaerobic
threshold
VO2  oxygen consumptionass of each ventricle were measured separately, and the eombined values were used for data analysis. Tei index was
btained (6). Ventricular diastolic function was assessed
ith measures derived from pulsed Doppler interrogation:
uration of pulmonary vein flow reversal during atrial
ystole; tissue Doppler peak early diastolic velocity (E=);
issue Doppler peak late diastolic velocity (A=); AV valve
eak early diastolic inflow velocity (E); AV valve peak late
iastolic inflow velocity (A); deceleration time of the early
V valve inflow (DT); duration of AV valve late diastolic
nflow (AT); and systemic ventricular flow propagation rate
FP). Two grading systems (7) were used (Table 2): 1)
estrictive pattern present versus absent, and 2) grades of 0
no impairment) to 3 (greatest impairment in diastolic
lling).
ardiac magnetic resonance (CMR). The CMR studies per-
ormed with 1.5-T scanners were centrally interpreted by a
ingle reader. Subjects were excluded if they were unable to
ooperate; had a pacemaker, defibrillator, permanent pace-
aker lead, implanted device considered a contraindication
ccording to institutional guidelines, or in some instances
ntravascular coils; or were 6 weeks from endovascular
evice implantation.
The standardized imaging protocol included electrocar-
iographically triggered gradient echo cine magnetic reso-
ance acquisitions in the vertical and horizontal long-axis
lanes, followed by contiguous short-axis imaging from the
V junction through the cardiac apex. Outcomes included
DV, ESV, mass indexed to BSA1.3, stroke volume (SV)
ndexed to BSA, and mass/EDV ratio (5).
xercise protocol. A maximal ramp exercise test was
erformed. Percent predicted of normal for maximum
xygen consumption (VO2) and oxygen consumption at
naerobic threshold (VAT) were calculated (8).
lectrocardiogram. A standard 12-lead electrocardiogram
as performed and locally interpreted.
erology. Resting BNP plasma concentration was centrally
easured with the Shinogi BNP-32 Human Assay (Mayo
linical Trial Services, Rochester, Minnesota) (2).
tatistical methods. Pre-specified subgroups were defined
y ventricular morphology, Fontan procedure type, age at
ardiac Anatomic Diagnosis of 546ontan Cross-Se tional Study Subjects
Table 1 Cardiac Anatomic Diagnosis of 546Fontan Cross-Sectional Study Subjects
Diagnosis n %
Tricuspid atresia 119 22
Hypoplastic left heart syndrome 112 21
Double inlet left ventricle 80 15
Heterotaxia 42 8
Double outlet right ventricle 41 8
Pulmonary atresia intact ventricular septum 33 6
Mitral atresia 31 6
Abnormal tricuspid valve 22 4
Atrioventricular canal defect 22 4
Other 38 7
he percentages have been rounded up here and in the other tables.nrollment quartile, age at Fontan procedure quartile, and
Fontan Cross-Sectional Study Patient Characteristics by Age at Enrollment
Table 2 Fontan Cross-Sectional Study Patient Characteristics by Age at Enrollment
Overall <9 yrs 9 to <11 yrs 11 to <15 yrs >15 yrs
Characteristic n Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or % p Value
n 546 138 (25%) 120 (22%) 169 (31%) 119 (22%)
Age at enrollment, yrs 11.9 3.4 7.9 0.7 10.0 0.6 12.8 1.2 17.0 1.1
Age at Fontan, yrs 3.4 2.1 3.0 1.3 3.0 1.5 3.2 1.9 4.6 3.0 0.001
Age at volume unloading surgery, yrs 1.6 1.6 0.9 0.9 1.1 1.0 1.4 1.0 3.4 2.1 0.001
Male gender 546 60% 58% 62% 65% 55% 0.305
Race 544 0.014
White 80% 70% 80% 82% 87%
Black 10% 14% 7% 11% 8%
Asian 3% 4% 3% 2% 1%
Other 8% 13% 10% 4% 3%
Hispanic 517 7% 8% 10% 4% 6% 0.318
Growth
Percentile for stature-for-age 544 26 22 31 22 31 0.242*
Z score for stature-for-age 544 0.7 1.3 0.7 1.4 0.6 1.3 0.8 1.3 0.6 1.0 0.316
Percentile for weight-for-age 545 37 36 27 29 48 0.021*
Z score for weight-for-age 545 0.4 1.4 0.4 1.2 0.5 1.4 0.6 1.5 0.2 1.2 0.085
BMI Z score 544 0.05 1.13 0.07 0.97 0.23 1.25 0.15 1.24 0.13 0.99 0.030
Fontan type 513 0.001
Atriopulmonary connection 13% 1% 3% 15% 36%
TCPC intracardiac lateral tunnel 59% 52% 62% 70% 50%
TCPC extracardiac lateral tunnel 13% 26% 19% 4% 3%
TCPC extracardiac conduit 13% 21% 15% 9% 6%
Other 2% 0% 1% 2% 5%
Ventricular type 546 0.023
LV 49% 46% 38% 53% 57%
RV 34% 36% 41% 34% 24%
Mixed 18% 19% 22% 13% 19%
Stage II surgery performed 546 75% 93% 88% 78% 35% 0.001
Predominant rhythm 518 0.255
Normal sinus rhythm 67% 63% 69% 71% 63%
Atrial escape 9% 11% 10% 7% 9%
Junctional escape 6% 9% 6% 5% 3%
Paced 8% 10% 4% 9% 11%
Other 11% 8% 12% 9% 15%
Currently on pacemaker 546 13% 12% 12% 11% 20% 0.087
Serology
Brain natriuretic peptide, pg/ml 510 13 (7, 26)† 11 11 14 17 0.020*
Continued on next page 87
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Table 2 Continued
Overall <9 yrs 9 to <11 yrs 11 to <15 yrs >15 yrs
Characteristic n Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or % p Value
Echocardiographic measures
Heart rate Z score 437 0.20 0.98 0.27 0.95 0.05 0.93 0.20 0.98 0.27 1.04 0.318
End-diastolic volume Z score 414 0.7 1.9 0.5 1.8 0.6 1.9 1.0 1.5 0.4 2.5 0.134
End-systolic volume Z score 414 0.2 2.4 0.4 2.1 0.2 2.4 0.1 2.1 0.6 3.3 0.206
Ejection fraction Z score 414 0.9 2.0 0.8 2.0 0.6 1.9 0.9 2.1 1.2 2.1 0.265
Stroke volume Z score 414 1.1 1.8 0.9 1.9 1.0 1.7 1.3 1.5 1.0 2.2 0.246
Mass Z score 406 1.0 2.3 0.7 2.0 0.9 2.3 0.8 2.1 1.7 2.7 0.011
Ejection fraction, % 414 59 10 59 10 60 10 59 11 57 11 0.252
Mass/volume ratio, g/ml 406 1.21 0.39 1.16 0.41 1.20 0.38 1.23 0.38 1.26 0.38 0.321
Mass/volume ratio Z score 406 2.65 3.22 1.97 3.06 2.41 2.97 2.86 3.15 3.49 3.63 0.011
dP/dtic, mm Hg/s 449 1,125 (802, 1,700)† 1,257 (n 115) 1,134 (n 106) 1,114 (n 134) 997 (n 94) 0.027*
Tei index (by tissue Doppler) 462 0.64 0.19 0.60 0.17 (n 117) 0.62 0.14 (n 99) 0.63 0.17 (n 144) 0.70 0.24 (n 102) 0.001
E=, cm/s 452 9.3 3.3 9.5 3.3 (n 113) 9.6 2.9 (n 97) 9.0 3.3 (n 141) 9.5 3.8 (n 101) 0.517
E/A ratio 344 1.48 (1.21, 1.92)† 1.45 (n 88) 1.46 (n 80) 1.55 (n 105) 1.48 (n 71) 0.883*
E/E= ratio 297 7.79 (5.94, 9.89)† 8.03 (n 74) 7.15 (n 66) 8.12 (n 94) 7.63 (n 63) 0.216*
Systemic ventricular FP rate, cm/s 143 64 20 63 16 (n 39) 64 19 (n 40) 69 24 (n 41) 57 15 (n 23) 0.107
Restrictive pattern present 344 52% 52% 54% 56% 44% 0.421
Diastolic dysfunction grade 327 0.438‡
Normal 28% 23% 27% 25% 38%
Impaired relaxation 9% 12% 8% 9% 8%
Pseudonormalization 41% 45% 47% 42% 29%
Restrictive 22% 20% 18% 24% 26%
Overall AV valve regurgitation 528 0.541‡
None 26% 27% 17% 33% 22%
Mild 55% 53% 59% 50% 60%
Moderate 19% 19% 23% 17% 17%
Severe 1% 0% 1% 0% 0%
Semilunar valve regurgitation 314 0.148‡
None 51% 57% 52% 54% 37%
Mild 40% 37% 42% 36% 50%
Moderate 9% 7% 6% 10% 13%
Cardiac MRI
n 161 161 33 37 50 41
End-diastolic volume/BSA1.3, ml/m2 85 25 96 26 89 29 81 20 79 23 0.011
End-systolic volume/BSA1.3, ml/m2 37 16 41 17 38 19 36 16 35 14 0.395
Ejection fraction, % 57 10 58 8 59 9 56 12 56 9 0.476
Stroke volume/BSA, ml/m2 51 14 52 12 52 14 48 14 51 15 0.500
Mass/BSA1.3, g/m2 72 21 75 17 70 18 68 19 76 26 0.182
Mass/volume ratio, g/ml 0.89 0.31 0.83 0.24 0.83 0.29 0.87 0.25 1.01 0.40 0.036
Continued on next page
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onnection or hemi-Fontan procedure). Subgroup differ-
nces in continuous outcomes were assessed with the t test
nd analysis of variance or nonparametric testing for highly
kewed outcomes. Differences in categorical outcome mea-
ures were assessed with the chi-square test and, if ordinal,
he Mantel-Haenszel test for linear trend. Modified Bon-
erroni and exact testing were applied to bootstrapped
amples to obtain a p value adjusted for multiple pairwise
omparisons (9). Analysis of covariance and multivariate
ogistic regression were used to determine whether out-
omes differed by subgroup after adjustment for age, with
og transformation for BNP. Additional multivariate linear,
ogistic, and multinomial regression modeling was used to
nalyze outcomes by age at Fontan and history of a Stage II
rocedure. All analyses were conducted with SAS version
.1 (SAS Institute, Cary, North Carolina) and S-Plus
ersion 6.2 (Insightful Corp., Seattle, Washington).
esults
verall cohort. The 546 subjects were 11.9 3.4 years old
t enrollment; 60% were male. The cohort was short (mean
SD, 34  30th percentile) and underweight (40  32th
ercentile). The most common diagnoses were tricuspid
tresia and hypoplastic left heart syndrome (Table 1), and
9% had an intracardiac lateral tunnel Fontan procedure. A
enestration was performed in 68% and was found to be
atent by echocardiography in 32%. After the Fontan
rocedure, stroke and/or thrombosis occurred in 8%, sei-
ures in 3%, and protein-losing enteropathy in 4%. The
revalences of developmental and cognitive abnormalities
nd surgical and catheter-based interventions have been
ublished (10).
The distribution of ventricular morphologic subgroups
as: LV, 49%; RV, 34%; and mixed, 18% (Table 2).
ne-third of subjects had predominant nonsinus rhythm,
0% had a history of atrial tachycardia, and 13% had a
acemaker. Ventricular mass and volume were obtained
ith echocardiography in 406 and 414 subjects, respectively,
nd by CMR in 161. Mean ejection fraction (EF) was 59 
0% by echocardiography and 57  10% by CMR. The EF
as normal (echocardiographic Z score 2) in 73%,
lthough mean echocardiographic EDV, SV, and EF were
ower and mass greater than those of normal subjects. The
igher values of mass-to-volume ratio measured by echo-
ardiography as compared with CMR reflect known echo-
ardiography underestimating ventricular volume and over-
stimating mass (11). Forty-nine percent of subjects had
emilunar valve regurgitation, and 74% had AV valve
egurgitation. Fifty-eight percent of subjects were taking an
ngiotensin-converting enzyme inhibitor at enrollment. Di-
stolic function grade was normal in 28%. The median
stimated maximum first derivative of ventricular pressure
dP/dtic) was 1,125 mm Hg/s (normal range 850 to 1,350mm Hg/s) (12). The Tei index was 0.64  0.19 (normalCo T E M Pe
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Children After the Fontan Procedure July 8, 2008:85–98ange 0.29 to 0.41). The median BNP was 13 pg/ml (range
4 to 652 pg/ml, mean 26  48 pg/ml).
The cohort had impaired exercise performance: mean %
redicted peak VO2 65  16%; % predicted VAT 78 
5%. Peak VO2 and VAT were in the normal range for 28%
nd 63%, respectively, independent of whether maximal
ffort was achieved.
Mean CHQ summary scores were lower than those of
istorically healthy control subjects (3) (45  12 vs. 53  9
or Physical, and 47  10 vs. 51  9 for Psychosocial).
ndividual scores were in the normal range in 81% and 87%,
espectively (Fig. 1).
ender. Male subjects had lower BNP levels than female
ubjects, even after adjustment for age (p  0.04). No
ender differences were present for % predicted peak VO2
nd % VAT. By both echocardiography and CMR, boys
ad larger EDV than girls (p  0.04), lower mass/EDV
atio (median by echocardiography 1.1 vs. 1.2, p  0.002),
nd higher SV/BSA by CMR imaging (53  14 vs. 48 
4, p  0.03).
ge at enrollment. The type of Fontan procedure differed
y age at enrollment (p  0.001) (Table 2). Older children
ere more likely to have undergone an atrio-pulmonary
onnection (36% in 15-year-old group vs. 1% to 15% in
ounger age groups), whereas younger children were more
ikely to have received a total cavopulmonary connection
TCPC) lateral tunnel (26% and 19% in the 2 younger age
roups vs. 5% otherwise). Ventricular morphology dif-
ered by age (p  0.02); in particular, the 15-year-old
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Figure 1 CHQ-PF Summary Scores
The distribution of Child Health Questionnaire-Parent Form (CHQ-PF) Physical and P
Pediatric Heart Network Fontan Cross-Sectional Study. The horizontal bars represeroup had a greater proportion with LV morphology than mhe 9- to 11-year-old group (pairwise adjusted p  0.03).
he BNP increased with age (medians 11 to 14 for the 3
oungest cohorts vs. 17 pg/ml for the 15-year-old group,
 0.020). Most other findings on echocardiography and
MR did not differ by age. Tei index increased with age
p  0.001). Exercise performance differed among age
roups and decreased with age (p  0.001).
entricular morphology. In general, ventricular function
utcomes were worse for the RV subgroup compared with
he LV and, to a lesser extent, the mixed subgroups (Table
). The EF Z score was 0.6  1.8, 1.4  2.3, and 0.5
2.1 for LV, RV, and mixed subgroups, respectively (p 
.001). Even after age adjustment, E= was lower and E/E=
as higher in the RV subgroup (p  0.001) (Fig. 2). The
V valve regurgitation was worst in the RV subgroup, as
as semilunar valve regurgitation (present in 65% for RV vs.
2% in LV and mixed subgroups, pairwise adjusted p 
.001).
Age-adjusted exercise performance was weakly associated
ith ventricular morphology, with the LV subgroup having
igher % predicted peak VO2 (3-group p  0.03) and %
redicted VAT (3-group p  0.06) than the non-LV
roups. Diastolic function grade, BNP, and CHQ summary
cores did not differ by ventricular morphology (Table 3).
ype of Fontan procedure. Few differences were found by
ype of Fontan procedure after adjustment for age. They
ncluded higher BNP in subjects with atriopulmonary con-
ection (raw median 18 pg/ml) compared with BNP in
ubjects with extracardiac conduits and lateral tunnels (raw
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social Summary scores from 543 children enrolled in the
95% confidence interval around the historical mean score for healthy children.sycho
nt theedians 13 and 10 pg/ml, respectively, pairwise adjusted
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Table 3 Fontan Cross-Sectional Study Patient Characteristics by Ventricular Morphology
LV RV Mixed
p Value
Age-Adjusted
p ValueCharacteristic Mean  SD, Median, or % Mean  SD, Median, or % Mean  SD, Median, or %
n 265 (49%) 184 (34%) 97 (18%)
Age at enrollment, yrs 12.0 10.8 10.7 0.011*
Age at Fontan, yrs 3.5 2.0 3.2 2.1 3.7 2.4 0.240
Age at volume unloading surgery, yrs 1.2 0.7 1.2 0.001*
Fontan type 0.017 0.102
Atriopulmonary connection 19% 7% 10%
TCPC intracardiac lateral tunnel 54% 67% 60%
TCPC extracardiac lateral tunnel 11% 14% 13%
TCPC extracardiac conduit 14% 11% 11%
Other 2% 1% 3%
Stage II surgery performed 68% 88% 69% 0.001 0.001
Serology
Brain natriuretic peptide, pg/ml 12 15 13 0.553* 0.417
Echocardiographic measures
Heart rate Z score 0.27 0.99 0.10 0.97 0.21 0.93 0.238 0.243
End-diastolic volume Z score 0.8 1.9 (n 219) 0.4 2.0 (n 156) 1.1 1.5 (n 39) 0.044 0.045
End-systolic volume Z score 0.1 2.2 0.8 2.7 0.4 2.1 0.001 0.001
Ejection fraction Z score 0.6 1.8 1.4 2.3 0.5 2.1 0.001 0.001
Stroke volume Z score 1.0 1.8 1.1 1.9 1.4 1.4 0.460 0.384
Mass Z score 0.8 2.2 (n 216) 1.1 2.3 (n 154) 1.9 1.8 (n 36) 0.018 0.006
Ejection fraction, % 60 9 (n 219) 56 12 (n 156) 61 11 (n 39) 0.001 0.001
Mass/volume ratio, g/ml 1.17 0.33 (n 216) 1.19 0.43 (n 154) 1.52 0.42 (n 36) 0.001 0.001
Mass/volume ratio z score 2.37 2.74 2.50 3.63 4.99 3.18 0.001 0.001
dP/dtic, mm Hg/s 1,209 (n 220) 1,077 (n 150) 1,073 (n 79) 0.071* 0.062
Tei index (by tissue Doppler) 0.58 (n 216) 0.63 (n 158) 0.64 (n 75) 0.001* 0.001
E=, cm/s 10.0 3.2 (n 222) 8.0 2.8 (n 155) 10.4 3.9 (n 75) 0.001 0.001
E/A ratio 1.48 (n 169) 1.45 (n 109) 1.54 (n 66) 0.730* 0.593
E/E= ratio 7.21 (n 147) 10.00 (n 94) 6.96 (n 56) 0.001* 0.001
Systemic ventricular FP rate, cm/s 64 18 (n 71) 64 22 (n 51) 62 19 (n 21) 0.907 0.899
Restrictive pattern present 53% 51% 52% 0.974 0.879
Diastolic dysfunction grade 0.035 0.100
Normal 32% 19% 32%
Impaired relaxation 9% 10% 8%
Pseudonormalization 33% 53% 42%
Restrictive 26% 18% 18%
Overall AV valve regurgitation 0.001 0.001
None 38% 12% 20%
Mild 48% 69% 49%
Moderate 15% 18% 31%
Severe 0% 1% 0%
Semilunar valve regurgitation 0.004 0.001
None 58% 35% 58%
Mild 34% 55% 32%
Moderate 8% 10% 10%
Cardiac MRI
n 100 55 38
End-diastolic volume/BSA1.3, ml/m2 79 22 (n 86) 93 29 (n 44) 92 24 (n 31) 0.003 0.012
End-systolic volume/BSA1.3, ml/m2 34 14 43 21 38 11 0.011 0.019
Ejection fraction, % 57 9 55 11 59 7 0.176 0.122
Stroke volume/BSA, ml/m2 49 13 51 13 57 16 0.015 0.019
Mass/BSA1.3, ml/m2 70 20 75 21 73 20 0.328 0.290
Mass/volume ratio, g/ml 0.92 0.32 0.87 0.33 0.82 0.22 0.274 0.402
Continued on next page
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redicted VAT differed by type of Fontan procedure (p 
.001); those who received an intracardiac lateral tunnel
adjusted mean  SE, 73  2%) had lower % predicted
AT than those with an atriopulmonary connection (84 
%) or with an extracardiac conduit (92  4%).
ontinued
Table 3 Continued
LV
Characteristic Mean  SD, Median, or % Me
Exercise performance measures
n 219
Peak VO2, ml/kg/min 27 7 (n 216)
Percent predicted peak VO2 66 17
Peak VO2 consumption at AT, ml/kg/min 19 6 (n 173)
Percent predicted VAT 80 24
Maximum heart rate, beats/min 155 23 (n 215)
Measures of functional status
CHQ-PF Physical Summary score 44.7 12.4
CHQ-PF Psychosocial Summary score 48.0 10.0
ercentages might not add to 100 due to rounding. The p value is from analysis of variance for conti
est p value.
Abbreviations as in Table 2.
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ventricular morphology. Red shaded regions indicate the 95% confidence interval f
ventricular.ge at Fontan procedure. Type of Fontan procedure
iffered by age at Fontan procedure (p  0.001) (Table 4).
ntracardiac lateral tunnel was most commonly used for
ontan procedures performed at 2 years of age (81%) and
ecreased steadily with age. Conversely, extracardiac tunnel
rocedures were performed in 6% of subjects who under-
RV Mixed
p Value
Age-Adjusted
p ValueSD, Median, or % Mean  SD, Median, or %
128 65
 7 (n 124) 26 7 (n 50) 0.445 0.226
63 16 63 16 0.141 0.031
 7 (n 94) 18 6 (n 50) 0.795 0.352
76 25 75 24 0.269 0.061
23 (n 126) 153 25 (n 64) 0.837 0.795
45.5 11.4 46.4 11.0 0.487 0.531
46.4 11.8 46.7 11.1 0.261 0.288
utcomes and chi-square test for categorical outcomes unless otherwise specified. *Kruskal-Wallis
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Table 4 Fontan Cross-Sectional Study Patient Characteristics by Age at Fontan Procedure
<2 yrs 2 to <3 yrs 3 to <4 yrs >4 yrs
Characteristic
Mean  SD,
Median, or %
Mean  SD,
Median, or %
Mean  SD,
Median, or %
Mean  SD,
Median, or % p Value
Age-Adjusted
p Value
n 113 191 104 138
Age at enrollment, yrs 11.1 10.8 10.8 13.3 0.001*
Age at volume unloading surgery, yrs 0.9 0.5 1.2 0.8 1.7 1.2 2.8 2.4 0.001
Fontan type 0.001 0.001
Atriopulmonary connection 6% 15% 15% 15%
TCPC intracardiac lateral tunnel 81% 62% 54% 42%
TCPC extracardiac lateral tunnel 6% 9% 15% 21%
TCPC extracardiac conduit 4% 13% 12% 20%
Other 2% 1% 4% 2%
Ventricular type 0.200 0.150
LV 40% 49% 57% 49%
RV 42% 35% 28% 30%
Mixed 19% 16% 15% 21%
Stage II surgery performed 69% 77% 73% 78% 0.365 0.001
Serology
Brain natriuretic peptide, pg/ml 15 12 15 13 0.661* 0.418
Echocardiographic measures
Heart rate Z score 0.14 0.82 0.36 1.04 0.32 1.00 0.07 0.95 0.003 0.002
End-diastolic volume Z score 0.9 1.8 0.6 1.7 0.5 2.3 0.6 1.9 0.471 0.470
End-systolic volume Z score 0.0 2.3 0.2 2.6 0.4 2.8 0.2 2.2 0.739 0.730
Ejection fraction Z score 0.9 2.0 0.8 2.1 1.0 1.8 1.0 2.2 0.839 0.924
Stroke volume Z score 1.4 1.6 1.0 1.6 1.0 2.0 1.0 2.0 0.407 0.378
Mass Z score 1.1 2.5 0.8 2.1 1.1 2.3 1.1 2.2 0.806 0.895
Ejection fraction, % 58 10 59 11 58 9 58 11 0.837 0.924
Mass/volume ratio, g/ml 1.29 0.41 1.18 0.37 1.19 0.37 1.20 0.41 0.166 0.154
Mass/volume ratio Z score 3.27 3.32 2.34 2.97 2.51 3.00 2.68 3.62 0.205 0.205
dP/dtic, mm Hg/s 1,209 1,164 1,039 1,081 0.257* 0.595
Tei index (by tissue Doppler) 0.57 0.60 0.62 0.65 0.001* 0.012
E=, cm/s 8.7 3.2 9.2 3.2 9.8 2.9 9.8 3.9 0.054 0.035
E/A ratio 1.50 1.50 1.49 1.37 0.047* 0.052
E/E= ratio 8.37 7.46 7.78 7.75 0.363* 0.034
Systemic ventricular FP rate, cm/s 62 17 64 20 68 20 62 20 0.555 0.583
Restrictive pattern present 47% 58% 54% 45% 0.228 0.324
Diastolic dysfunction grade 0.218† 0.515
Normal 30% 22% 33% 31%
Impaired relaxation 8% 7% 7% 14%
Pseudonormalization 41% 45% 38% 39%
Restrictive 21% 26% 22% 17%
Overall AV valve regurgitation 0.002† 0.010
None 32% 27.1% 26.7% 18.8%
Mild 55% 57.5% 50.5% 55.6%
Moderate 13% 14.9% 22.8% 25.6%
Severe 0% 1% 0% 0%
Semilunar valve regurgitation 0.314† 0.620
None 53% 56% 46% 46%
Mild 39% 38% 48% 40%
Moderate 8% 6% 7% 15%
Cardiac MRI
n 39 65 35 54
End-diastolic volume/BSA1.3, ml/m2 82 24 88 27 86 27 84 22 0.739 0.785
End-systolic volume/BSA1.3, ml/m2 35 15 38 16 37 17 39 16 0.635 0.477
Ejection fraction, % 58 9 58 8 58 10 54 11 0.112 0.206
Stroke volume/BSA, ml/m2 50 13 53 13 51 14 49 16 0.622 0.748
Mass/BSA1.3, ml/m2 70 20 70 18 69 17 77 26 0.236 0.252
Mass/volume ratio, g/ml 0.90 0.32 0.86 0.36 0.85 0.23 0.94 0.27 0.538 0.859Continued on next page
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Children After the Fontan Procedure July 8, 2008:85–98ent Fontan at 2 years and in 21% of subjects who
nderwent Fontan at 4 years. Age at Fontan was similar
or those who did and did not undergo a Stage II procedure
3.5  2.0 years vs. 3.2  2.3 years).
Rhythm status was associated with age at Fontan (p 
.0001). Normal sinus rhythm was present in 70% to 74% of
hose with Fontan performed under 3 years of age and 59%
o 62% of those with Fontan performed at 3 years. This
ssociation remained after adjustment for age at enrollment
p  0.01).
Age-adjusted mean Tei index (0.60, 0.62, 0.66, and 0.68
n the 4 Fontan age groups, p  0.001) was significantly
orse for subjects who had a Fontan at later ages, even after
djustment for age at enrollment and for ventricular mor-
hology. Moderate to severe AV valve regurgitation was
ore common in children with Fontan performed at 3
ears (23% to 26%) compared with children with Fontan
erformed at 2 or at 2 to 3 years (13% to 16%). After
djustment for age at enrollment, greater severity of AV
alve regurgitation was associated with older age at Fontan
p  0.010). Subjects with RV or mixed ventricular mor-
hology who underwent the Fontan at older ages were more
ikely to have worse E=, and RV subjects who underwent
ontan at older ages had worse E/E=, even after adjustment
or age at enrollment (morphology by age at Fontan
nteractions p  0.05).
The BNP, CHQ summary scores, and systolic function
id not differ by age at Fontan (Table 4), and after adjusting
or age, exercise performance was also unrelated to age at
ontan.
tage II procedure. Subjects who underwent a Stage II
rocedure (66%) were younger at enrollment (10.9  2.9
ears vs. 14.7  3.2 years) and were less likely to have
ndergone an atrio-pulmonary connection (7% vs. 33%),
ven after age adjustment (Table 5). The distribution of LV,
V, and mixed subgroup subjects who underwent a Stage II
rocedure (44%, 40%, and 16%, respectively) was different
ontinued
Table 4 Continued
<2 yrs 2 to <3
Characteristic
Mean  SD,
Median, or %
Mean 
Median,
Exercise performance measurements
n 80 140
Peak VO2, ml/kg/min 26 7 27 7
Percent predicted peak VO2 64 16 66 1
Peak VO2 consumption at AT, ml/kg/min 18 6 20 7
Percent predicted VAT 74 23 83 2
Maximum heart rate, beats/min 156 21 155 2
Measures of functional status
CHQ-PF Physical Summary score 45.4 12.2 45.0 1
CHQ-PF Psychosocial Summary score 45.4 11.8 47.2 1
ercentages might not add to 100 due to rounding. The p value is from analysis of variance for conti
est p value. †Mantel-Haenszel test for linear trend p value.
Abbreviations as in Table 2.han in those who did not (62%, 16%, and 22%, respec- wively; p  0.001). No differences were found in predomi-
ant rhythm by Stage II status. After adjustment for age,
tage II surgery was not associated with ventricular function
r exercise performance, except for higher ventricular mass
n subjects who underwent Stage II surgery (age-adjusted
ean  SE 1.2  0.1 vs. 0.4  0.3, p  0.008).
Stage II surgery was associated with lower age-adjusted
ean log BNP for LV subgroup but not RV and mixed
ubgroups (Stage II  ventricular morphology interaction
 0.008). The Psychosocial Summary score was lower in
tage II subjects (age-adjusted mean  SE 46.4  0.6 vs.
9.7 1.0, p 0.008) and was not explained by ventricular
orphology or other factors. No other age-adjusted study
utcomes differed significantly by Stage II surgery status
ithin morphologic subgroup.
iscussion
his study is the largest to date of children who have
ndergone the Fontan operation. Systematic data on med-
cal history, demographic variables and quantitative mea-
ures of ventricular systolic and diastolic function, exercise
erformance, neurohormonal response, heart rhythm, and
unctional health status were obtained. Strengths of the
tudy design are contemporaneous data collection, central
nterpretation of key measures, and large cohort size from
ultiple geographically dispersed centers. The novelty of
he study follows, in part, from sophisticated measurement
f ventricular diastolic function, with tissue Doppler echo-
ardiography, BNP plasma concentration measurement,
nd large size of the study that permitted for the first time
statistically robust assessment of how outcomes differ by
entricular morphology, age at Fontan, and history of Stage
I procedure.
verall cohort. VENTRICULAR FUNCTION. Ejection frac-
ion was normal in the majority (73%) of subjects. Our
nding of smaller-than-normal EDV contrasts with a study
3 to <4 yrs >4 yrs
Mean  SD,
Median, or %
Mean  SD,
Median, or % p Value
Age-Adjusted
p Value
81 111
27 8 25 7 0.132 0.425
65 18 63 15 0.441 0.893
20 7 17 6 0.006 0.102
80 26 74.4 20.8 0.049 0.151
153 26 153 25 0.695 0.736
44.8 12.4 46.0 9.6 0.862 0.736
48.4 9.5 47.9 10.3 0.210 0.227
utcomes and chi-square test for categorical outcomes unless otherwise specified. *Kruskal-Wallisyrs
SD,
or %
7
7
2
2.8
1.1
nuous ohere EDV was 1.6 times larger than normal (13). Such
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Table 5 Fontan Cross-Sectional Study Patient Characteristics by Superior Cavopulmonary Connection (Stage II Surgery) Performed
Characteristic
Without Stage II Without Stage II
p Value
Age-Adjusted
p ValueMean  SD, Median, or % Mean  SD, Median, or %
n n  408 n  138
Age at enrollment, yrs 10.3 15.7 0.001* —
Age at Fontan, yrs 3.5 2.0 3.2 2.3 0.318 0.001
Age at volume unloading surgery, yrs 0.8 2.8 0.001* 0.001
Male 60% 60% 1.00 0.497
Race 0.024 0.491
White 78% 86%
Black 11% 9%
Asian 2% 3%
Other 9% 2%
Hispanic 7% 5% 0.550 0.588
Growth
Percentile for stature-for-age 24 31 0.085* 0.195
Z score for stature-for-age 0.7 1.3 0.5 1.1 0.056 0.054
Percentile for weight-for-age 32 48 0.001* 0.005
Z score for weight-for-age 0.5 1.4 0.1 1.1 0.001 0.001
BMI Z score 0.13 1.17 0.18 1.00 0.004 0.003
Fontan type 0.001 0.022
Atriopulmonary connection 7% 33%
TCPC Intracardiac lateral tunnel 61% 56%
TCPC extracardiac lateral tunnel 16% 3%
TCPC extracardiac conduit 16% 2%
Other 1% 7%
Ventricular type 0.001 0.108
LV 44% 62%
RV 40% 16%
Mixed 16% 22%
Currently on pacemaker 14.2% 13.8% 1.000 0.059
Serology
BNP, pg/ml† 11.8 17.6 0.001* 0.066
Predominant rhythm 0.772 0.292
Normal sinus rhythm 66% 70%
Atrial escape 9% 9%
Junctional escape 6% 4%
Paced 9% 6%
Other 10% 11%
Echocardiographic measures
Heart rate Z score 0.17 0.99 0.29 0.92 0.267 0.247
End-diastolic volume Z score 0.6 1.8 0.9 2.3 0.167 0.111
End-systolic volume Z score 0.3 2.2 0.0 3.0 0.400 0.190
Ejection fraction Z score 0.9 2.1 0.9 2.0 0.983 0.340
Stroke volume Z score 1.0 1.8 1.3 1.8 0.086 0.168
Mass Z score 1.0 2.1 0.8 2.6 0.323 0.008
Ejection fraction, % 59 11 58 10 0.966 0.343
Mass/volume ratio, g/ml 1.21 0.39 1.21 0.39 0.957 0.316
Mass/volume ratio Z score 2.57 3.10 2.92 3.63 0.356 0.380
dp/dtic, mm Hg/s 1,182 (n 341) 1,030 (n 108) 0.044* 0.368
Tei index (by tissue Doppler) 0.6 (n 346) 0.6 (n 116) 0.303* 0.175
E=, cm/s 9.5 3.4 (n 338) 9.0 3.2 (n 114) 0.226 0.293
E/A ratio 1.48 (n 247) 1.48 (n 97) 0.985* 0.530
E/E= ratio 7.79 (n 215) 7.80 (n 82) 0.400* 0.177
Systemic ventricular FP rate, cm/s 65 21 60 15 0.111 0.219
Restrictive pattern present 53% 49% 0.472 0.932Continued on next page
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ver time, such as earlier volume-unloading surgery. Smaller
DV, as compared with normal subjects, might be a
eflection of aerobic deconditioning and might contribute to
he blunted ability to increase stroke volume with exercise (14).
Our finding of abnormal diastolic function in 72% of
hildren who had undergone a Fontan has not been previ-
usly reported and is concerning. These indexes are depen-
ent on cardiac loading conditions and are unable to
istinguish between enhanced chamber compliance and
mpaired relaxation (7). However, given our findings, future
tudies using invasive approaches are needed to ascertain
hether these children are at risk for diastolic heart failure.
unctional health status. Over 80% of subjects scored in
he normal range on the CHQ. However, on average the
arents perceived their children as having lower physical and
sychosocial functional status than that of historic healthy
ontinued
Table 5 Continued
Characteristic
Without Stage II
Mean  SD, Median, or %
Diastolic dysfunction grade
Normal 25%
Impaired relaxation 9%
Pseudonormalization 44%
Restrictive 21%
Overall AV valve regurgitation grade
None 25%
Mild 56%
Moderate 19%
Severe 1%
Semilunar valve regurgitation grade
None 52%
Mild 39%
Moderate 9%
Cardiac MRI
n 108
End-diastolic volume/BSA1.3, ml/m2 87 27
End-systolic volume/BSA1.3, ml/m2 38 17
Ejection fraction, % 57 10
Stroke volume/BSA, ml/m2 51 14
Mass/BSA1.3, g/m2 73 21
Mass/volume ratio g/ml 0.88 0.28
Exercise performance measurements
n 290
Peak VO2, ml/kg/min 27 7.0
Percent predicted peak VO2 66 17
Peak VO2 consumption at AT, ml/kg/min 20 7
Percent predicted VAT 81 26
Max heart rate, beats/min 155 24
Measures of functional status
CHQ-PF Physical Summary score 45.3 12.1
CHQ-PF Psychosocial Summary score 46.5 11.1
ercentages might not add to 100 due to rounding. The p value is from analysis of variance for co
ank sum test p value. †There was significant age-adjusted interaction of Stage II status and ven
ompared with those who did not in the LV subgroup (log BNP 2.51  0.07 vs. 2.98  0.11, p  .
Abbreviations as in Table 2.ontrol subjects. The lower Physical Summary scores are cimilar to those for children who have undergone thoracic
rgan transplantation or cardioverter defibrillator implanta-
ion (15,16).
xercise performance. Maximal exercise performance was
ower than normal and worse in older subjects, consistent
ith previous studies (14). The same mechanisms proposed
reviously to impair exercise performance in single ventricle
ubjects, including absence of a subpulmonary pumping
hamber, abnormal endothelial cell function, increased sys-
emic vascular resistance, decreased muscle mass, and de-
onditioning, are likely present in our subjects (1,14). The
nding that exercise performance (% predicted VAT) was
owest in the intracardiac lateral tunnel group, among
ontan types, was an unexpected and unexplained finding.
NP. The subjects demonstrated a wide range of BNP
lasma concentrations. The mean concentration was similar
o subjects without congenital heart disease and those with
Without Stage II
p Value
Age-Adjusted
p ValueMean  SD, Median, or %
0.280 0.830
33%
9%
33%
24%
0.725 0.406
29%
54%
17%
0%
0.830 0.482
48%
44%
8%
53
81 21 0.109 0.658
36 14 0.391 0.739
56 9 0.555 0.986
50 13 0.596 0.884
69 19 0.205 0.130
0.90 0.36 0.751 0.455
113
25 7 0.015 0.207
60 15 0.001 0.067
17 6 0.001 0.658
72 21 0.001 0.346
153 22 0.390 0.490
45.3 11.3 0.974 0.555
49.3 9.8 0.010 0.008
us outcomes and chi-square test for categorical outcomes unless otherwise specified. *Wilcoxon
morphologic subtype (p  0.008), with lower BNP for subjects who underwent Stage II surgery
ut no difference in BNP by Stage II surgery status for subjects with RV or mixed type morphology.ntinuo
tricularongenital heart disease without ventricular dysfunction and
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July 8, 2008:85–98 Children After the Fontan Procedureower than that of single ventricle patients with systemic
entricular failure (17). Our finding of lower age-adjusted
NP concentrations in male versus female subjects is
onsistent with adult data but not with a report of a gender
ifference only in healthy post-pubertal children (18).
entricular morphologic subgroups. SYSTOLIC AND DIA-
TOLIC FUNCTION. Our finding of apparently impaired
ystolic function in the RV subgroup relative to the LV and
ixed subgroups is consistent with the general opinion that
he structure of the RV is suboptimal for a systemic ventricle
1). The greater prevalence of diastolic dysfunction in the
V subgroup, measured by E= and E/E=, is not likely a
onsequence of difference in loading conditions compared
ith the LV and mixed subgroups (19). Of note, the
ajority of subjects in each morphologic subgroup had Tei
ndex, E=, and E/E= values outside a 2-SD range for normal
hildren (20).
alve regurgitation. The tricuspid valve is thought to be
ore likely to fail as a systemic AV valve, similar to
oncerns about the relative inadequacy of the RV as a
ystemic ventricle. Subjects with RV morphology were most
ikely and those with LV morphology were least likely to
ave AV valve regurgitation, consistent with that notion.
he higher prevalence of semilunar valve regurgitation in
ubjects with RV morphology might be related to the aortic
econstruction and intrinsic characteristics of the pulmonary
neo-aortic) valve in patients with hypoplastic left heart
yndrome.
unctional health status and BNP. Although measures of
entricular performance and exercise capacity varied accord-
ng to ventricular morphology, CHQ scores and BNP levels
id not.
ge at Fontan. Subjects who were older at time of Fontan
ad worse AV valve function and decreased likelihood of
eing in sinus rhythm. Poorer valve function and a decrease
n sinus rhythm might be related to a longer period of
olume overloading (21). These negative associations with
lder age at Fontan might be used as a rationale to complete
he Fontan at an earlier age.
istory of stage II procedure. The performance of a Stage
I procedure in single ventricle patients follows from the
eneral assumption that this procedure decreases volume
oading and its negative effects. Although we postulated that
tage II surgery might be beneficial in some patients, we
ound that a Stage II procedure was not associated with
aboratory measures except for BNP and ventricular mass
nd a negative association with Psychosocial Summary
core. Our findings suggest that further study is needed to
ssess the impact of performing a Stage II procedure.
tudy limitations. This study was limited in several re-
pects. Because only survivors of the Fontan procedure were
tudied, our findings might not reflect the characteristics of
ubjects who died in the years after the Fontan. Although
he generalizability of our findings is supported by the
nrolled subjects being of similar age and functional health
tatus as the eligible but non-consenting subjects (2) and
1eing from geographically dispersed regions, our subjects
ere recruited exclusively from major medical centers.
unctional health status was measured with parental report
nstruments, which may not match child perception (22).
onclusions
his largest-to-date multi-center study of children who
ave undergone a Fontan procedure provides an overview of
unctional health status, ventricular performance, and exer-
ise performance in current survivors of the Fontan proce-
ure. Ventricular systolic function and functional health
tatus were within normal range in the majority of subjects.
entricular function and valvular function were negatively
ssociated with RV morphology. Atrioventricular valve
unction was negatively associated with older age at Fontan
ompletion. Continued follow-up of these subjects will
etermine whether functional health status is eventually
elated to measures of ventricular diastolic function. Effec-
ive strategies to preserve ventricular and valvular function,
articularly for patients with RV morphology, are needed.
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